Form 4 for EW Edwards Lifesciences
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-16 · accession 0001225208-26-001987 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | 2026-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $75.87 | -199 | 39.7K | -0.5% | -$15.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | F | D | 199 | $75.87 | 39,699 | D | — | — |